A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer

Publisher： Karger

E-ISSN： 1421-9794|53|6|454-460

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.6, 2007-10, pp. : 454-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Docetaxel and Infusional Cisplatin in Advanced Non-Small-Cell Lung Cancer

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 126-131

Karger

Access to resources Recommend Favorite

A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 197-203

Karger

Access to resources Recommend Favorite

Advanced Gastric Cancer with Liver and Lymph Node Metastases Successfully Resected after Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil

By  

Chemotherapy, Vol. 60, Iss. 4, 2015-04 ,pp. : 224-227

Karger

Access to resources Recommend Favorite